Proteomics Market is Set to Reach $67.22 Billion by 2029 - Arizton

According to Arizton’s latest research report, the global proteomics market is growing at a CAGR of 12.94% during 2023-2029.                

Looking for More Information? Click: https://www.arizton.com/market-reports/proteomics-market 

Report Scope:              

Market Size (2029): $67.22 Billion  

Market Size (2023): $32.39 Billion  

CAGR (2023-2029): 12.94%  

Historic Year: 2020-2022  

Base Year: 2023  

Forecast Year: 2024-2029  

Market Segmentation: Product, Applications, End-Users, and Geography 

Geographical Analysis: North America, Europe, APAC, Latin America, And Middle East & Africa 

Personalized Medicine: Shaping the Future of Healthcare with Proteomics 

Personalized medicine, or precision medicine, tailors treatments to an individual’s unique molecular profile, genetics, lifestyle, and environment, offering more effective and cost-efficient healthcare solutions. Proteomics, the study of proteins, plays a crucial role in this approach by helping identify biomarkers and develop new drugs. The US FDA recognizes proteomics as essential for personalized medicine, with 95% of FDA-approved drugs targeting proteins and most diagnostic tests relying on protein analysis. The number of personalized medicines on the market has doubled from 132 in 2019 to over 280 in 2021. Notable examples include Genentech’s T-Dxd drug for HER2-positive breast cancer and Quanterix’s CardioMetRx test for heart failure. Collaborations like Azenta, Inc.’s partnership with FinnGen in 2024, further emphasize the growing importance of proteomics in personalized medicine. This expanding focus on proteomics is driving significant market growth and the demand for more tailored healthcare solutions. 

North America’s Dominance in the Global Proteomics Market 

In 2023, North America held the largest market share of over 33% in the global proteomics market, with the US contributing 93% and Canada 7%. The region is expected to grow at a healthy CAGR of 12.51% during the forecast period. This growth is driven by the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and genetic disorders, which fuel the demand for personalized medicine. With 2.1 million cancer patients, 40 million people living with diabetes, and 22 million CVD cases, there is significant demand for personalized treatments, early diagnosis, and R&D in proteomics. 

The US, in particular, has seen significant advancements in personalized medicine, driven by high healthcare expenditure, easy access to treatments, and increasing demand for proteomics in drug development. The region’s biotech and pharmaceutical sectors, with their growing focus on biomarker discovery, are also creating a strong demand for proteomics services. This trend is expected to continue, making drug discovery and personalized medicine key drivers of proteomics growth in North America. 

Competitive Landscape of the Global Proteomics Market 

The global proteomics market is highly competitive, with several leading players dominating the industry, alongside emerging companies challenging large and medium-sized market leaders. Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, and BGI Genomics are some of the key players, collectively holding a significant share of the market. These companies continually expand their proteomics solutions and services to meet client needs and comply with international regulations while improving product efficiency and strengthening their market presence. 

Key strategies such as partnerships and collaborations have intensified market competition, allowing major players to expand their capabilities and increase revenue shares. Rapidly growing vendors like Danaher and PerkinElmer are also making notable strides, thanks to their global reach, diversified portfolios, and strong focus on innovation and research. These factors contribute to their growing influence in the market, shaping the future of proteomics.  

Vendors’ Recent Activities & Developments  

• In 2024, Thermo Fischer Scientific announced the acquisition of Olink Holding AB, a pioneer in next-generation proteomics solution development. Olink’s expertise lies in advanced proteomics discovery and development, supporting both academic institutes and biopharma companies.  
• In 2023, SomaLogic, one of the leading companies in data-driven proteomics technology, and Standard BioTools Inc. announced that they had entered into a definitive agreement to combine in an all-stock merger.  
• In 2023, Danaher acquired Abcam, one of the leading companies in the proteomics market, for around $5.7 billion. Abcam offers tools and reagents for diagnostic, drug discovery, and scientific research, including proteomics.  
• In 2023, Bruker Corporation and Biognosys AG announced a strategic partnership. Under this partnership, Biognosys will lead proteomics and proteogenomic CRO services and will access Bruker’s leading 4D proteomics timsTOF technology for high-precision proteomics development. 

Explore More: https://www.arizton.com/market-reports/proteomics-market  

Vendors List 

• Agilent Technologies 
• Bio-Rad Laboratories  
• Thermo Fisher Scientific 
• Danaher  
• PerkinElmer  
• BGI Group 
• Bruker 
• DiaSorin 
• HORIBA 
• Illumina 
• INOVIQ 
• LI-COR Biosciences 
• Nautilus Biotechnology 
• Proteome Factory 
• QIAGEN 
• Rhythm Biosciences 
• Shimadzu Scientific Instruments 
• Seer 
• Waters 
• Charles River Laboratories 
• Applied Biomics 
• Creative Proteomics 
• Poochon Scientific 
• SomaLogic 
• Vproteomics 
• AnteoTech 
• Biognosys 
• GeNei 
• Grace Bio-Labs 
• ITSI-BIO 
• MSAID 
• Olink 
• Proteomics International 
• Quanterix 
• Alamar Biosciences 
• Nicoya Lifesciences 
• Promega

Segmentation & Forecast 

Product 

• Consumables & Reagents 
• Instrument & Software 
• Services 

Applications 

• Drug Discovery & Development and Translational Research 
• Clinical Applications  
• Forensic and Applied Proteomics 

End-users 

• Pharma & Biotech Companies 
• Academic & Research Institutes/Laboratories 
• Hospitals 
• Diagnostics Labs and Forensic Labs 

Geography 

• North America 
• The US 
• Canada 

Europe 

• Germany 
• France 
• The UK 
• Italy 
• Spain 

APAC 

• Japan 
• China 
• India 
• South Korea 
• Australia 

Latin America 

• Brazil 
• Mexico 
• Argentina 

Middle East & Africa 

• Turkey 
• South Africa 
• Saudi Arabia  

The Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the proteomics market. Request for Free Sample to get a glance of the report now: https://www.arizton.com/market-reports/proteomics-market  

What Key Findings Our Research Analysis Reveals?              

How big is the global proteomics market? 

What are the factors driving the global proteomics market growth? 

What is the growth rate of the global proteomics market? 

Who are the major players in the global proteomics market? 

Which region will have the highest growth in the global proteomics market?    

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4644   

Other Related Reports that Might be of Your Business Requirement         

3d Cell Culture Market - Global Outlook & Forecast 2024-2029 

https://www.arizton.com/market-reports/3d-cell-culture-market 

Europe Cell And Gene Therapy Market - Focused Insights 2024-2029 

https://www.arizton.com/market-reports/europe-cell-gene-therapy-market-size-analysis   

Why Arizton?              

100% Customer Satisfaction              

24x7 availability – we are always there when you need us              

200+ Fortune 500 Companies trust Arizton's report              

80% of our reports are exclusive and first in the industry              

100% more data and analysis              

1500+ reports published till date                          

Post-Purchase Benefit              

• 1hr of free analyst discussion              
• 10% off on customization                            

About Us:              

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.              

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.              

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                            

Contact Us              

Call: +1-312-235-2040              

          +1 302 469 0707              

Mail: enquiry@arizton.com              

Contact Us: https://www.arizton.com/contact-us              

Blog: https://www.arizton.com/blog              

Website: https://www.arizton.com/